Dudediligence.

Liminatus Pharma, Inc

LIMNNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Filings

Newest first

The annual , the quarterly and the filed between them when something material happens.

  1. Sep 298-KRegulation FD disclosure and listing notice or transfer3.017.019.01
  2. Aug 188-KBylaws or fiscal year changed and Regulation FD disclosure3.013.035.037.019.01
  3. Aug 1410-QQuarterly report
  4. Aug 48-KShareholder vote5.07
  5. Jul 308-KOther events8.019.01
  6. Jul 248-KOther events and listing notice or transfer3.018.019.01
  7. Jul 2213GPassive stake of 5% or more (13G), filed by Samda Biolab Co.
  8. Jul 68-KMaterial agreement and acquisition or sale of assets completed1.012.013.025.039.01
  9. Jun 24S-1Registration of new shares
  10. Jun 38-KMaterial agreement and unregistered sale of shares1.013.023.038.019.01
  11. Jun 3424B3Prospectus for an offering
  12. May 278-KListing notice or transfer3.019.01
  13. May 208-KMaterial agreement1.019.01
  14. May 1510-QQuarterly report
  15. Mar 3110-KAnnual report
  16. Mar 48-KBylaws or fiscal year changed5.039.01
  17. Feb 188-KMaterial agreement and other events1.018.019.01
  18. Feb 18424B4Prospectus for an offering
  19. Feb 11S-1Registration of new shares
  20. Feb 98-KMaterial agreement and unregistered sale of shares1.013.029.01
  21. Jan 268-KListing notice or transfer3.01
  22. Nov 25, 20258-KListing notice or transfer3.01
  23. Nov 14, 202510-QQuarterly report
  24. Oct 4, 202510-QQuarterly report
  25. Aug 25, 20258-KListing notice or transfer3.019.01
  26. Aug 14, 20258-KRegulation FD disclosure7.019.01
  27. Aug 13, 2025424B3Prospectus for an offering
  28. Jul 17, 20258-KMaterial agreement and unregistered sale of shares1.013.02
  29. Jul 11, 20258-KOfficer or director change5.02
  30. Jul 3, 20258-KOther events8.01
  31. Jun 24, 2025S-1Registration of new shares
  32. Jun 24, 20258-KRegulation FD disclosure7.019.01
  33. Jun 24, 20258-KOther events8.019.01
  34. Jun 4, 20258-KListing notice or transfer3.019.01
  35. May 31, 202510-QQuarterly report
  36. May 31, 20258-K/AAcquisition or sale of assets completed (amended)2.019.01
  37. May 6, 20258-KMaterial agreement and acquisition or sale of assets completed1.012.013.023.034.015.015.025.035.055.067.018.019.01
  38. Feb 7, 2025424B3Prospectus for an offering